Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status

Frontiers in Pharmacology
Ahmad FasseehZoltán Kaló

Abstract

Implementation of health technology assessment (HTA) is still in an early stage with some heterogeneity in the Middle East and North Africa (MENA). Our objective was to assess the current and future status of HTA implementation in the MENA region by focusing on regional commonalities. Preparatory discussions for the first ISPOR conference in the MENA region indicated some potentially generalizable trends of HTA roadmaps. To widen the perspective, a policy survey was conducted among conference participants by applying an HTA implementation scorecard. Discussion group members helped to validate key conclusions during and after the conference. Health policy experts in MENA countries would like to facilitate HTA implementation and expect significant changes with some generalizable directions in 10 years compared to the current status according. HTA capacity building has to be strengthened by more graduate and postgraduate programs. Increased public budget and enhanced institutionalization are necessary success factors of HTA implementation. The scope of HTA has to be extended from pharmaceuticals to non-pharmaceutical technologies and to revision of previous policy decisions. Although cost-effectiveness with explicit threshold rema...Continue Reading

References

Dec 23, 2003·Cost Effectiveness and Resource Allocation : C/E·Raymond HutubessyTessa Tan-Torres Edejer
Dec 25, 2009·International Journal of Technology Assessment in Health Care·Finn Børlum KristensenUNKNOWN European network for Health Technology Assessment (EUnetHTA)
Aug 21, 2013·Health Policy·Ruth LopertKalipso Chalkidou
Mar 10, 2015·International Journal of Technology Assessment in Health Care·Sarah KleijnenWim G Goettsch
May 21, 2015·International Journal of Technology Assessment in Health Care·Andres Pichon-RiviereMichael Drummond
Jan 15, 2016·Health Economics·Zoltán KalóFinn Boerlum Kristensen
Jan 23, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Praveen ThokalaMaarten Ijzerman
Feb 26, 2016·Applied Health Economics and Health Policy·Samer Hamidi, Fevzi Akinci
Dec 23, 2017·PharmacoEconomics·Sarah GarnerSuzanne R Hill
Jan 1, 2013·Value in Health Regional Issues·Zoltán KalóUNKNOWN ISPOR Hungary Chapter
Jan 1, 2013·Value in Health Regional Issues·Gihan H ElsisiSherif Abaza
Jan 22, 2019·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Finn Børlum KristensenAllan Wailoo
Apr 24, 2019·Journal of Pharmaceutical Policy and Practice·Ali Hadi AbdullahZoltán Kaló
Jan 19, 2020·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Olga LöblováPiotr Ozierański

❮ Previous
Next ❯

Citations

May 13, 2020·Expert Review of Pharmacoeconomics & Outcomes Research·Qais AlefanKaren Rascati
May 25, 2021·Expert Review of Pharmacoeconomics & Outcomes Research·Mennatollah Nagy Sharkawy, Ilker Dastan
May 21, 2021·Value in Health Regional Issues·Emad AlmomaniZoltán Kaló
Jun 26, 2021·Frontiers in Pharmacology·Mohamed Naser FarghalyZoltán Kaló
Jul 13, 2021·Expert Review of Pharmacoeconomics & Outcomes Research·Mouaddh Abdulmalik NagiMontarat Thavorncharoensap
Aug 24, 2021·Value in Health Regional Issues·Samar Farid, Darrin Baines

❮ Previous
Next ❯

Software Mentioned

MCDA
INEAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Technology Assessment in Health Care
Valentina Prevolnik Rupel
International Journal of Technology Assessment in Health Care
Wija OortwijnLora Todorova
International Journal of Technology Assessment in Health Care
Bertalan NémethZoltán Kaló
© 2021 Meta ULC. All rights reserved